market Research / Analysis Genotyping Assay Market by Product-converted

Genotyping Assay Market by Product & Services Region - Global Analysis &
Forecast By 2030
Market Industry Reports (MIR) has published a new report titled “ Genotyping Assay Market -
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.”
The global genotyping assay market was valued at over US$ 7 Bn. in 2017 and is
expected to grow at a double digit CAGR during the forecasted period. The
growth of this market can be attributed to the factors such as, the reducing prices
of DNA sequencing, technological advancements, growing awareness on
customized medicine, and rising importance of the method in drug development.
Technological advancement in PCR to boost the market growth
Polymerase Chain Reaction or PCR is the key technology used by the professionals and
researchers for rapid and accurate detection of genetic changes. The introduction of newer
technologies in combination with computer programs and database, such as inverse PCR, reverse
transcription PCR, assembly PCR and Quantitative PCR (Q-PCR) is expected to fuel the growth of
the market. Developments in the sequencing technologies have transformed the sequencing
methods into a multifaceted, adaptable molecular tool. Moreover, introduction of automated models
in sequencing and high-throughput platforms offer potential growth opportunities in clinical molecular
modeling studies, new, gene profiling, chemical entity interactions and genome sequencing.
Browse key industry insights spread across 150 pages with market data tables & figures & charts
from the report, Genotyping Assay Market by Product & Services (Reagents & Kits,
Instruments, Services) Technique (PCR, Sequencing, Electrophoresis), End Users
(Diagnostic & Research laboratories, Pharmaceutical & Bio Technique Companies) and
Region - Global Analysis & Forecast 2019-2030 in detail along with the table of
contents: https://www.marketindustryreports.com/7/genotyping-assay-market
Increasing number of genetic disorders to propel the market growth
The global genotyping assay market is propelled by a number of factors. One among them is the
increase in the number of genetic diseases all around the world. Following that is the general
awareness regarding personalized medicine all around the world especially in the developed regions
of the world. According to the Parkinson’s Foundation, more than 60 thousand people are diagnosed
with the major genetic disorder, Parkinson’s disease in the U.S. every year. Moreover, the number is
expected to reach 1 million by 2020
Get Your Free PDF Sample Copy @ https://www.marketindustryreports.com/pdf/7
Stringent regulatory policies to affect the small market players
According to the new guidelines by FDA for gene sequencing the testing guidelines and standard
are regulated by the three agencies consists of Centers for Medicare and Medicaid Services (CMS),